Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu Establishes South African Subsidiary

NEW YORK (GenomeWeb News) – Shimadzu's wholly-owned subsidiary in the United Arab Emirates has established another wholly-owned subsidiary in South Africa in order to tap into the southern African markets, the company announced today.

Shimadzu South Africa, established by Shimadzu Middle East and Africa on Oct. 1, will concentrate on the university and research markets in South Africa, the largest market for analytical and measurement instruments in the country, as well as the minerals, food, agriculture, and pharmaceutical spaces.

As the country moves away from mineral dependency to a knowledge-based economy, the government is doubling R&D as a percentage of gross domestic product and pushing for greater training of people in science, engineering, and technology, according to Shimadzu.

"This is expected to lead to increased demand for analytical and measuring instruments by universities and government research organizations," Shimadzu said in a statement.

Over the medium- and long-term, the firm expects to expand across the entire Sub-Saharan African region.

The South African operation is headquartered in Johannesburg and has 13 employees. In addition to South Africa, it will provide sales and services to Namibia, Botswana, Zambia, Zimbabwe, Mozambique, Madagascar, Lesotho, Mauritius, Seychelles, and Swaziland.

Shimadzu said that it expects the South African subsidiary to generate about $8.6 million in sales in 2012, with sales increasing to $13.2 million in 2014.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more